About this product
LETROZOLE is an oral medication, indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer. Letrozole is a selective non-steroidal aromatase inhibitor. It significantly lowers serum estradiol concentrations and has no detectable effect on formation of adrenal corticosteroids or aldosterone.
Composition
Letrozole USP 2.5 mg Hard tablets Each box contains 50 tablets
Storage
Store at room temperature between 15 oC – 30 oC, away from light and moisture. Do not store in the bathroom. Keep all medicines away from children and pets.
Products
HALOTESTIN
FLUOXYMESTERONE is used to treat symptoms of low testosterone in adult men who have hypogonadism.
STANOZOLOL
STANOZOLOL is used to promote weight gain following extensive surgery,
chronic infection, or severe trauma, and in other cases that result in inadequate
weight gain or maintenance.
OXANDROLONE
OXANDROLONE is indicated as an alternate or adjunctive therapy in patients
for the promotion of weight gain following weight loss.